As 2024 draws to an end, several significant publications have advanced our understanding of inflammatory bowel disease treatment. Key studies offer important insights and a few are worth highlighting...
...continue reading at --> substack.com/home/post/p-...
#IBDSky #GISky
Thank you to #AIBD for recognizing our work as the Best of AIBD Case Reports 2024!
🔑: #Alpha-gal syndrome may confer increased risk for first-dose infusion reaction to ustekinumab in pts with #IBD
💫: Pts who have an infusion reaction can safely tolerate SC ustekinumab injection 💉without issue
